Skip to content

Advertisement

  • Original article
  • Open Access

Analysis of the regulatory mechanism of deoxynivalenol production using omics

AMB Express20188:161

https://doi.org/10.1186/s13568-018-0688-y

  • Received: 18 February 2018
  • Accepted: 26 September 2018
  • Published:

Abstract

Fusarium species are plant pathogens that produce various mycotoxins. Here, the regulatory mechanism of deoxynivalenol production in Fusarium asiaticum was analyzed using proteomic, metabolomic and transcriptomic methods. F. asiaticum was induced to produce deoxynivalenol by adding agmatine to the culture medium. Subsequently, metabolites of the glycolysis system were increased but mRNAs of the corresponding proteins were not up regulated. We speculated that this phenomenon was due to the up regulation of the 6-fructokinase and pyruvate kinase proteins, which are key enzymes of glycolysis. We discuss the relationship of metabolism with the regulation of deoxynivalenol production in F. asiaticum.

Keywords

  • F. asiaticum
  • Deoxynivalenol (DON)
  • Omics
  • Glycolysis system
  • iTraq

Introduction

Fusarium species cause wheat and other small grain fusarium head blight (FHB) and corn ear rot in maize (Suga et al. 2008). There are at least 13 types of the Fusarium species at least physiologically different (Yli-Mattila et al. 2009), which produce mycotoxins, are a problem worldwide as plant pathogenic fungi, particularly because they decrease the yields of cereals. Among Fusarium species, F. asiaticum adapts to lower temperatures than another Fusarium species, preferring tropical climates, and can grow even at temperatures around 15 °C (Zhang et al. 2010). Therefore, F. asiaticum is widely distributed in Southeast Asia including Japan. In Japan, there are many areas where rain falls in the latter part of the wheat growing season and the final production tends to be damaged by mold contamination.

Various kinds of mycotoxins are produced by Fusarium species. Among them, deoxynivalenol (DON) is known to have acute toxicity, causing major disorders of the gastrointestinal tract such as vomiting and diarrhea (Pestka and Smolinski 2005; Chu 1998; Larsen et al. 2004). DON is sesquiterpenes with a trichothecene ring (Fig. 1). It is difficult that this chemical substance to completely inactivate in ordinary processing and cooking steps (Sugita-Konishi et al. 2006), so it is particularly important to prevent contamination at the production stage. Because of current food control policies in developed countries, DON pollution hardly ever causes acute toxicity. However, it is unknown whether long-term intake of low concentrations can be prevented and, especially in domestic animals and children, there is concern about the effects of DON including weight loss and reduction of immunity. In a study in Britain, DON was detected in the urine of > 95% of children and adolescents (Papageorgiou et al. 2018).
Fig. 1
Fig. 1

Chemical structure of deoxynivalenol (DON)

Cereals contaminated with fungi cannot be distributed, so when contaminated crops are accidentally mixed with harvests from other fields, all of the cereals, including the healthy ones, must be disposed of, resulting in economic losses.

The amount of DON produced varies depending on the environment and the state of the plant host. However, the regulatory mechanism of DON production is not well understood.

Fusarium asiaticum strain MAFF111889, which we used for this experiment, does not normally produce DON in modified Czapek liquid medium (pH 7.7) but does produce DON when agmatine is added to the medium. F. asiaticum induced to produce DON by adding agmatine shows increases in many metabolites and mRNAs (Suzuki et al. 2013).

A proteomice analysis method using isobaric tags for relative and absolute quantitation (iTraq) was published in 2004 (Ross et al. 2004) and can comprehensively compare the abundances of proteins among multiple samples. In the iTraq method, tags that can be distinguished from each other are made by replacing some atoms with stable isotopes without changing the molecular structure of the reporter group. The balance group also uses stable isotopes and is adjusted so that the molecular weight of the entire tag does not change. Thus, four or eight distinguishable tags are included in the iTraq reagent with the same structure, and the same mass as a whole.

Using iTraq, we found that three enzymes of the glycolysis system were up regulated when agmatine was added to induce DON production. In particular, 6-fructokinase and pyruvate kinase behaved very similarly to way they do in the metabolism of cancer cells. In recent years, metabolic fluctuations and posttranslational modifications have been clearly linked to human cancer cells (Hitosugi and Chen 2014). In particular, the regulation of metabolism by posttranslational modification mechanisms has attracted attention. Here, we discuss the changes in metabolites and posttranslational modifications in the regulation of DON production in F. asiaticum.

Materials and methods

Stocks, media, growth conditions and chemical substances

Fusarium asiaticum strain MAFF111889 was used in this study. This strain produces DON but does not produce nivalenol. The strain was maintained on potato dextrose agar purchased from Becton–Dickinson (Sparks, MD, USA). To determine the growth rate and DON yield, the strain was cultured in modified Czapek liquid medium (pH 7.7) containing 30.0 g/l sucrose, 2.0 g/l NaNO3, 15 mM MgSO4 and H2O (pH 7.7). Agmatine was purchased from Wako Pure Chemical (Osaka, Japan). Conidia or hyphae of F. asiaticum were inoculated into potato dextrose liquid medium and preincubated at 25 °C and 100 rpm for 3 days. The conidia or mycelia of the preincubated sample were collected by filtration and 100 mg were inoculated into medium with or without 2 mM agmatine and incubated at 25 °C for 5 days at 100 rpm.

Determination of DON yield

The DON concentration in the culture filtrate was determined using the Veratox DON ELISA kit (Neogen Corporation, Lansing, MI, USA) according to the manufacturer’s instructions. Culture filtrates were initially diluted 1:10 in phosphate-buffered saline (pH 7.5) to provide a detection range of 0.5–6 ppm. Further sequential 1:10 dilutions were made to quantify toxin levels in samples that contained levels above the detection range.

Proteins sample preparation

Culture filtrates (1 g) were frozen in liquid nitrogen and crushed to a fine powder. Then, 1 ml of 10 mM Tris–HCl (pH 7.5) was added and the sample was centrifuged at 2000g for 15 min. The centrifuged supernatant was treated with 1000 U of nuclease (Takara Bio Inc., Shiga, Japan) at 4 °C, and thereafter acetone precipitation was repeated four times at − 20 °C. The precipitate was recovered by centrifugation at 2000g for 15 min and suspended in a rehydration buffer (GE Healthcare UK Ltd., Buckinghamshire, England) to prepare a protein sample.

Proteome analysis

The protein samples (50 μg each) were acetone-washed, reduced, alkylated and trypsin-digested according to the iTraq protocol (Sciex, Framingham, MA, USA). All labelled samples were combined to make a pooled sample. The peptides were desalted on a Strata-X 33-μm polymeric reversed phase column (Phenomenex, Torrance, CA, USA) and dissolved in a buffer containing 2% acetonitrile and 0.1% formic acid before separation by high pH on an Agilent 1100 high-performance liquid chromatography system (HPLC) using a Zorbax C18 column (2.1 × 150 mm, Agilent Technologies, Palo Alto, CA, USA). The peptides were eluted with a linear gradient of 20 mM ammonium formate, 2% acetonitrile to 20 mM ammonium formate, and 90% acetonitrile at 0.2 ml/min. The 95 fractions were concatenated into 12 fractions and dried. Each fraction was analyzed by electrospray ionization mass spectrometry using the Shimadzu Prominence nano HPLC system (Shimadzu Corporation, Kyoto, Japan) coupled to a 5600 Triple time-of-flight mass spectrometer (Sciex). The peptides were loaded onto a Zorbax 300SB-C18 3.5-μm column (Agilent Technologies) and separated with a linear gradient of water/acetonitrile/0.1% formic acid (v/v). Two types of samples, + agmatine and control, were used, and 2 × 4 (independent experimental samples) = 8 samples were analyzed simultaneously.

Data analysis

Spectral data were analyzed using the ProteinPilot™ 5.0 Software (Sciex). The results were searched against the UniProt F. graminearum database (Version: August 2017; 16,432 sequences), a comprehensive, audited database designed specifically for mass spectrometry applications. For proteins that could not be identified with UniProt, the KEGG database was also used as a reference. The ProteinPilot™ Software calculates a percentage of confidence that reflects the probability that the hit is a false positive. At a 95% confidence level, there is a false positive identification rate of around 5%.

Transcriptomic and metabolomic analysis

The expression level ratios of mRNAs and the content ratios of metabolites were measured as described in a previous paper (Suzuki et al. 2013).

Results

Proteomic analysis by liquid chromatography coupled with tandem mass spectrometry (LC–MS/MS) using iTraq reagent

LC–MS/MS with the iTraq reagent was used for comparative analysis of the intracellular proteins from F. asiaticum cultured with and without 2 mM agmatine. According to a t test, 506 peptides were identified with a p-value of 0.05 or less. Among them, 174 peptides were found in F. asiaticum cells less than 2 mM agmatine, which produced DON and contained over 1.5 times more protein than the control. Compared with the control, 135 peptides had decreased intracellular content less than 2 mM agmatine. Furthermore, 460 peptides were compared with DNA microarrays results. About 78% of protein and mRNA ratios were consistent (data not shown).

Glycolysis system

Among the enzymes belonging to the glycolytic system, the peptide contents of three proteins, ATP-dependent 6-phosphofructokinase, 2,3-bisphosphoglycerate-independent phosphoglycerate mutase and pyruvate kinase, were increased by the addition of agmatine (4.4–6 times). ATP-dependent 6-phosphofructokinase and pyruvate kinase are considered to control the flow of glycolysis system. The mRNA content ratios were 0.6–1.48 by the addition of agmatine (Table 1).
Table 1

Proteomic and transcriptomic analysis of enzymes belonging to the glycolysis system

Accession #

FGSG

Protein peptide

mRNA*

Description

p-value (agmatine ±)

Fold change (agmatine ±)

Fold change (agmatine ±)

tr|I1RA62|I1RA62_GIBZE

FG00387.1

0.0457

0.8318

1.18

Phosphoglucomutase

tr|I1RP86|I1RP86_GIBZE

FG05843.1

0.0397

1.3677

1.03

Glucose-6-phosphate isomerase

tr|I1RYK0|I1RYK0_GIBZE

FG09456.1

0.01

4.6132

1.48

ATP-dependent 6-phosphofructokinase

tr|I1RGB2|I1RGB2_GIBZE

FG02770.1

0.0161

0.9376

0.74

Fructose-bisphosphate aldolase

tr|V6RLM7|V6RLM7_GIBZE

FG06702.1

0.0401

1.2359

1.10

Triose-phosphate isomerase

tr|V6R5I4|V6R5I4_GIBZE

FG03992.1

0.0456

1.0186

1.01

Phosphoglycerate kinase

tr|A0A098E4T8|A0A098E4T8_GIBZE

FG06055.1

0.0058

6.0813

0.61

2,3-bisphosphoglycerate-independent phosphoglycerate mutase

tr|I1RCM5|I1RCM5_GIBZE

FG01346.1

0.0003

1.0375

0.99

2-phosphoglycerate dehydratase

tr|I1RTL7|I1RTL7_GIBZE

FG07528.1

0.006

4.4055

0.86

Pyruvate kinase

Protein peptides were detected using LC–MS/MS as described in the “Materials and methods” section. The data marked with asterisk (*) are quoted from Suzuki et al. (2013)

Proteomic, metabolomic and transcriptomic changes related to methionine

Methionine metabolites include methionine, S-adenosylmethionine, S-adenosylhomocysteine, homocysteine, cystathionine and cysteine. Of these, the S-adenosylmethionine, S-adenosylhomocysteine and cystathionine contents were increased 1.6- to 2.7-fold (Table 2). Homocysteine and cysteine could not be detected. In addition, S-adenosylmethionine synthetase, adenosylhomocysteinase and homocysteine methyltransferase peptides were up regulated when agmatine was added, but cystathionine beta-synthase was down regulated in both the transcriptome and proteome (Table 3).
Table 2

Changes in metabolites of the methionine cycle after addition of agmatine

Compound name

KEGG ID

Agmatine+/agmatine−

Ratio

p-value

Methionine

C00073,C00855,C01733

1.9

0.034

S-Adenosylmethionine

C00019

2.0

0.010

S-Adenosylhomocysteine

C00021

2.7

0.008

Homocysteine

C05330

ND

ND

Cystathionine

C00542,C02291

1.6

0.002

Cysteine

C00097,C00736,C00793

ND

ND

The content ratios of metabolites were measured as described in a previous paper (Suzuki et al. 2013)

Table 3

Proteomic and transcriptomic analysis of enzymes belonging to methionine cycle after addition of agmatine

Accession #

FGSG

Protein

mRNA

Description

p-value (agmatine ±)

Fold change (agmatine ±)

Fold change (agmatine ±)

tr|I1RA94|I1RA94_GIBZE

FG00421.1

0.0489

1.2023

1.82

S-Adenosylmethionine synthetase

tr|A0A0E0SID1|A0A0E0SID1_GIBZE

FG05615.1

0.0450

1.0471

2.46

Adenosylhomocysteinase

tr|I1S241|I1S241_GIBZE

FG10825.1

0.0446

0.9817

1.56

Homocysteine methyltransferase

tr|V6RDH3|V6RDH3_GIBZE

FG06544.1

0.0459

0.6194

0.80

Cystathionine beta-synthase

Protein peptides were detected using LC–MS/MS as described in the “Materials and methods” section. Accession # is the number in UniProt. Data marked with an asterisk (*) are quoted from Suzuki et al. (2013)

TCA cycle, GABA shunt and glyoxylic acid cycle

Many of the proteins belonging to the TCA cycle were more down regulated than the corresponding mRNAs by addition of agmatine. In addition, pyruvate dehydrogenase, which produces acetyl-CoA from pyruvate in mitochondria, was down regulated by agmatine in both proteomic and transcriptomic analysis (Table 4). Conversely, the mRNA content of pyruvate dehydrogenase kinase, which phosphorylates pyruvate dehydrogenase and inhibits the influx of pyruvate into mitochondria, was up regulated. However, pyruvate dehydrogenase kinase could not be detected by proteomic analysis. Of the proteins belonging to the TCA cycle, only the isocitrate dehydrogenase protein was up regulated by agmatine addition; the expression ratio of the mRNA was also up regulated. ATP citrate lyase, which converts citrate from the mitochondrial matrix into cytoplasmic acetyl-CoA, was increased about 3.3-fold for the peptide and 2.8-fold for the mRNA. Furthermore, the abundance ratio of the isocitrate lyase protein of the glyoxylic acid cycle was increased by agmatine, which was similar to the mRNA.
Table 4

Proteomic and transcriptomic analysis of enzymes of TCA cycle and the GABA shunt

Accession #

FGSG

Protein peptide

mRNA*

Description

p-value (agmatine ±)

Fold change (agmatine ±)

Fold change (agmatine ±)

tr|I1RN88|I1RN88_GIBZE

FG05454.1

0.0421

0.8318

1.50

Pyruvate dehydrogenase

tr|I1RUQ3|I1RUQ3_GIBZE

FG07953.1

0.0499

0.8091

1.39

Aconitate hydratase

tr|I1RNY6|I1RNY6_GIBZE

FG05733.1

0.0171

3.1623

2.05

Isocitrate dehydrogenase

tr|I1RKB2|I1RKB2_GIBZE

FG04309.1

0.467

1.4322

1.44

2-oxoglutarate dehydrogenase

tr|I1REE2|I1REE2_GIBZE

FG02030.1

0.0191

0.8395

1.30

Succinate-coa ligase

tr|V6RRM0|V6RRM0_GIBZE

FG08712.1

0.0443

0.912

0.83

Fumarate hydratase 

tr|I1RFI4|I1RFI4_GIBZE

FG02461.1

0.0414

0.9638

0.91

Malate dehydrogenase

tr|I1RPR1|I1RPR1_GIBZE

FG06039.1

0.5779

3.2211

2.65

ATP-citrate lyase  

tr|I1RCC4|I1RCC4_GIBZE

FG09896.1

0.2567

2.466

2.21

Isocitrate lyase  

Protein peptides were detected using LC–MS/MS as described in the “Materials and methods” section. Accession # is the number in UniProt. Data marked with an asterisk (*) are quoted from Suzuki et al. (2013)

Discussion

We reported that except for pyruvate, metabolites belonging to the glycolytic system were increased in F. asiaticum cells producing DON in previous papers (Suzuki et al. 2013). Because the amounts of mRNAs encoding enzymes belonging to the glycolytic system did not increase, it seemed that the metabolites were increased by something other than gene expression changes, such as protein degradation being suppressed or protein activity being increased.

Among the enzymes belonging to the glycolytic system, the peptide contents of three proteins, ATP-dependent 6-phosphofructokinase, 2,3-bisphosphoglycerate-independent phosphoglycerate mutase and pyruvate kinase, were increased by the addition of agmatine. 2,3-bisphosphoglycerate-independent phosphoglycerate mutase is a metalloenzyme that is found particularly in eubacteria and higher plants (Li et al. 2011). Elucidation of the role of this enzyme in the flow of the glycolysis system and DON production in Fusarium spp. will be the subject of a future study.

Phosphofructokinase (PFK) is an enzyme that acts on fructose-6-phosphate and catalyzes one of the key regulatory and rate-limiting steps of glycolysis (Mor et al. 2011). PFK1 converts fructose-6-phosphate to fructose 1,6-phosphate (F-1, 6-BP) and PFK2 converts it to fructose-2, 6-bisphosphate (F-2, 6-BP). There are three types of human PFK1, the muscle, liver and platelet types, which are called PFKM, PFKL and PFKP, respectively (Webb et al. 2015). PFK2 is a strange protein containing a kinase domain and a phosphatase domain, and has been reported to contribute to the Warburg effect of cancer cells in recent years (Ros and Schulze 2013). It is believed that in cancer cells, the TIGAR protein is down regulated by the loss of p53 function, thereby up regulating F-2, 6-BP (Bensaad et al. 2006). As a result, the level of F-2, 6-BP remains high in the tumor and is thought to act as a strong positive stimulus for FPK1. PFK2 is encoded by four different genes (pfkfb1, pfkfb2, pfkfb3 and pfkfb4) in vertebrates. In particular, PFKFB3 exhibits significant kinase activity, enhancing the F-2, 6-BP level and glycolysis efflux (Yalcin et al. 2009). Arginine-methylated PFKFB3 activates glycolytic flux by increasing F-2, 6-BP, an allosteric activator of PFK1 (Mor et al. 2011). As metabolites of the methionine cycle were increased by the addition of agmatine, there is a high possibility that S-adenosylmethionine in this metabolic pathway acts as a donor of the methyl group in protein methylation. Our transcriptome and proteome results revealed that the mRNA and protein contents of cystathionine synthase were also down regulated by agmatine addition. These results mean that metabolites necessary for methylation are increased by agmatine. A model of the methionine cycle when agmatine is added is shown in Fig. 2.
Fig. 2
Fig. 2

Changes in the methionine cycle after addition of agmatine. ↑: Up regulated by agmatine. ↓: Down regulated by agmatine

In Aspergillus niger, citrate resistant PFK1 was activated to a high level by allosteric activators (Mesojednik and Legiša 2005; Mlakar and Legiša 2006; Capuder et al. 2009). These kinetic properties were attributed to the 49 kDa subunit, which is a relatively small PFK1 molecule because other eukaryotic PFK1s are about 85 kDa. Further studies showed that a shorter 49-kDa fragment was formed by a two-step posttranslational modification of the native 85-kDa enzyme (Dunaway 1983; Poorman et al. 1984). In this experiment, F-2, 6-BP could not be detected by metabolomic analysis (data not shown) and the presence of PFK2 could not be detected by proteomic analysis either. However, because the FKP1 peptide remained at a high level during DON production, it is possible that some posttranslational modifications may have occurred.

Pyruvate kinase (EC 2.7.1.40) is the most complex regulatory enzyme of glycolysis, catalyzing the third irreversible step of glucose consumption, and normally controls the outflow from the pathway in eukaryotes. This final step yields ATP and pyruvate. The pyruvate kinase of higher animals has four isozymes, L type, R type, M1 type and M2 type, which are expressed tissue-specifically (Imamura and Tanaka 1982). Among these isoforms, pyruvate kinase M2 (PKM2) is gaining attention. PKM2 functions in glycolysis in a tetramer state and produce pyruvic acid by transferring phosphate from phosphoenolpyruvate to ADP. Dimeric PKM2 is abundant in cancer cells, but PKM2 does not have pyruvate kinase activity in dimer form, causing metabolic changes that may potentially be metabolically advantageous to cancer cells (Gao et al. 2012). In our results, the expression ratio of the pyruvate kinase mRNA was not increased by the addition of agmatine, but the abundance of the detected peptide was increased. Additionally, in metabolomic analysis, pyruvate was decreased and no conversion to lactic acid was detected (data not shown) after agmatine addition.

Both the peptide and mRNA were down regulated for pyruvate dehydrogenase, which produces acetyl-CoA from pyruvate in mitochondria, by agmatine addition. Conversely, the mRNA content of pyruvate dehydrogenase kinase, which phosphorylates pyruvate dehydrogenase and inhibits the influx of pyruvic acid into mitochondria, was up regulated. Unfortunately, the peptide of pyruvate dehydrogenase kinase could not be detected in this experiment. Pyruvate dehydrogenase kinase is an important mitochondrial enzyme that blocks the production of acetyl-CoA by selectively inhibiting the activity of pyruvate dehydrogenase through phosphorylation. Pyruvate dehydrogenase kinase is up regulated in cancer cells, which is considered to be one of the factors contributing to the up regulation of glycolytic metabolism in cancer cells (Zhang et al. 2014).

Pyruvate dehydrogenase kinase 1 deficiency in F. graminearum resulted in an increase in pyruvate dehydrogenase activity, causing growth retardation and increased pigmentation (Gao et al. 2016). Inhibition of pyruvate dehydrogenase kinase has been suggested as a therapeutic approach for the development of anticancer drugs (Steták et al. 2007). In the future, understanding the activity regulation mechanism of pyruvate dehydrogenase kinase will be necessary for the suppression of DON production.

In F. asiaticum cultured with agmatine, both the peptide content and the mRNA expression level of ATP-citrate lyase were high. Because acetyl-CoA cannot pass through the mitochondria, it binds to oxaloacetate to become citric acid and exits the mitochondria into the cytoplasm. ATP-citrate lyase then cleaves citric acid to produce acetyl-CoA for DON synthesis. In addition, peptides of the gamma-aminobutyric acid (GABA) shunt and glyoxylic acid cycle were up regulated by agmatine, which was consistent with transcriptome results described in our previous paper. Among the GABA shunt proteins, the succinate-semialdehyde dehydrogenase protein peptide is considered highly up regulated when GABA formed from agmatine enters the TCA cycle as succinic acid. Oxaloacetate enters the glyoxylate cycle outside the mitochondria and contributes to the production of acetyl-CoA.

As described above, F. asiaticum recognizes agmatine as a resistance factor from the plant when acquiring substances necessary for tissue synthesis such as energy, nucleic acids and NADPH through glycolysis and the pentose phosphate pathway. By inhibiting the TCA cycle through the activation of pyruvate dehydrogenase kinase, apoptosis of mitochondria is prevented and proliferation is enabled. This study shows that omics analysis is effective for elucidating the regulatory mechanism of DON production but further detailed research is necessary.

Abbreviations

DON: 

deoxynivalenol

iTraq: 

isobaric tags for relative and absolute quantitation

LC–MS/MS: 

liquid chromatography coupled with tandem mass spectrometry

PFK: 

phosphofructokinase

F-1,6-BP: 

fructose 1,6-phosphate

F-2,6-BP: 

fructose 2,6-phosphate

PKM2: 

pyruvate kinase M2

GABA: 

gamma-aminobutyric acid

Declarations

Authors’ contributions

YI carried out the experimental studies and wrote the manuscript text. The author read and approved the final manuscript.

Acknowledgements

We thank Robbie Lewis, MSc, from Edanz Group (http://www.edanzediting.com/ac) for editing a draft of this manuscript.

Competing interests

The author declares no competing interests.

Availability of data and materials

All data in this manuscript were deposited in National Agriculture and Food Research Organization, Ibaraki, Japan.

Consent for publication

Not applicable.

Ethics approval and consent to participate

Not applicable.

Funding

The Ministry of Agriculture, Forestry and Fisheries supported this work.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors’ Affiliations

(1)
National Agriculture and Food Research Organization, 2-1-2 Kannondai, Tsukuba Ibaraki, 305-8642, Japan

References

  1. Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K (2006) TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126:107–120View ArticleGoogle Scholar
  2. Capuder M, Solar T, Benčina M, Legiša M (2009) Highly active, citrate inhibition resistant form of Aspergillus niger 6-phosphofructo-1-kinase encoded by a modified pfkA gene. J Biotechnol 144:51–57View ArticleGoogle Scholar
  3. Chu FS (1998) Mycotoxins-occurrence and toxic effect. encyclopedia of human nutrition. Sadler M, Strain JJ, Caballero B, eds. Academic Press, New York. pp 858–869Google Scholar
  4. Dunaway GA (1983) A review of animal phosphofructokinase isozymes with an emphasis on their physiological role. Mol Cell Biochem 52:75–91View ArticleGoogle Scholar
  5. Gao X, Wang H, Yang JJ, Liu X, Liu ZR (2012) Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase. Mol Cell 45:598–609View ArticleGoogle Scholar
  6. Gao T, Chen J, Shi Z (2016) Fusarium graminearum pyruvate dehydrogenase kinase 1 (FgPDK1) is critical for conidiation, mycelium growth, and pathogenicity. PLoS ONE 11:e0158077View ArticleGoogle Scholar
  7. Hitosugi T, Chen J (2014) Post-translational modifications and the Warburg effect. Oncogene 33:4279–4285View ArticleGoogle Scholar
  8. Imamura K, Tanaka T (1982) Pyruvate kinase isozymes from rat. Methods Enzymol 90:150–165View ArticleGoogle Scholar
  9. Larsen JC, Hunt J, Perrin I, Ruckenbauer P (2004) Workshop on trichothecenes with a focus on DON: summary report. Toxicol Lett 153:1–22View ArticleGoogle Scholar
  10. Li Z, Galvin BD, Raverdy S, Carlow CK (2011) Identification and characterization of the cofactor-independent phosphoglycerate mutases of Dirofilaria immitis and its Wolbachia endosymbiont. Vet Parasitol 176:350–356View ArticleGoogle Scholar
  11. Mesojednik S, Legiša M (2005) Posttranslational modification of 6-phosphofructo-1-kinase in Aspergillus niger. Appl Environ Microbiol 71:1425–1432View ArticleGoogle Scholar
  12. Mlakar T, Legiša M (2006) Citrate inhibition-resistant form of 6-phosphofructo-1-kinase from Aspergillus niger. Appl Environ Microbiol 72:4515–4521View ArticleGoogle Scholar
  13. Mor I, Cheung EC, Vousden KH (2011) Control of glycolysis through regulation of PFK1: old friends and recent additions. Cold Spring Harb Symp Quant Biol 76:211–216View ArticleGoogle Scholar
  14. Papageorgiou M, Wells L, Williams C, White K, De Santis B, Liu Y, Debegnach F, Miano B, Moretti G, Greetham S, Brera C, Atkin SL, Hardie LJ, Sathyapalan T (2018) Assessment of urinary deoxynivalenol biomarkers in UK children and adolescents. Toxins 10(2):50. https://doi.org/10.3390/toxins10020050 View ArticlePubMed CentralGoogle Scholar
  15. Pestka JJ, Smolinski AT (2005) Deoxynivalenol: toxicology and potential effects on humans. J. Toxicol. Environ. Health B Crit. Rev. 8:39–69View ArticleGoogle Scholar
  16. Poorman RA, Randolph A, Kemp RG, Heinrikson RL (1984) Evolution of phosphofructokinase-gene duplication and creation of new effector sites. Nature 309:467–469View ArticleGoogle Scholar
  17. Ros S, Schulze A (2013) Balancing glycolytic flux: the role of 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatases in cancer metabolism. Cancer Metab 1:8View ArticleGoogle Scholar
  18. Ross PL, Huang YN, Marchese JN, Williamson B, Parker K, Hattan S, Khainovski N, Pillai S, Dey S, Daniels S, Purkayastha S, Juhasz P, Martin S, Bartlet-Jones M, He F, Jacobson A, Pappin DJ (2004) Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteom 3:1154–1169View ArticleGoogle Scholar
  19. Steták A, Veress R, Ovádi J, Csermely P, Kéri G, Ullrich A (2007) Nuclear translocation of the tumor marker pyruvate kinase M2 induces programmed cell death. Cancer Res 67:1602–1608View ArticleGoogle Scholar
  20. Suga H, Karugia GW, Ward T, Gale LR, Tomimura K, Nakajima T, Miyasaka A, Koizumi S, Kageyama K, Hyakumachi M (2008) Molecular characterization of the Fusarium graminearum species complex in Japan. Phytopathology 98:159–166View ArticleGoogle Scholar
  21. Sugita-Konishi Y, Park BJ, Kobayashi-Hattori K, Tanaka T, Chonan T, Yoshikawa K, Kumagai S (2006) Effect of cooking process on the deoxynivalenol content and its subsequent cytotoxicity in wheat products. Biosci Biotechnol Biochem 70:1764–1768View ArticleGoogle Scholar
  22. Suzuki T, Kim YK, Yoshioka H, Iwahashi Y (2013) Regulation of metabolic products and gene expression in Fusarium asiaticum by agmatine addition. Mycotoxin Res 29:103–111View ArticleGoogle Scholar
  23. Webb BA, Forouhar F, Szu FE, Seetharaman J, Tong L, Barber DL (2015) Structures of human phosphofructokinase-1 and atomic basis of cancer-associated mutations. Nature 523:111–114View ArticleGoogle Scholar
  24. Yalcin A, Telang S, Clem B, Chesney J (2009) Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer. Exp Mol Pathol 86:174–179View ArticleGoogle Scholar
  25. Yli-Mattila T, Gagkaeva T, Ward TJ, Aoki T, Kistler HC, O’Donnell K (2009) A novel Asian clade within the Fusarium graminearum species complex includes a newly discovered cereal head blight pathogen from the Russian Far East. Mycologia 101:841–852View ArticleGoogle Scholar
  26. Zhang H, Zhang Z, van der Lee T, Chen WQ, Xu J, Xu JS, Yang L, Yu D, Waalwijk C, Feng J (2010) Population genetic analyses of Fusarium asiaticum populations from barley suggest a recent shift favoring 3ADON producers in southern China. Phytopathology 100:328–336View ArticleGoogle Scholar
  27. Zhang S, Hulver MW, McMillan RP, Cline MA, Gilbert ER (2014) The pivotal role of pyruvate dehydrogenase kinases in metabolic flexibility. Nutr Metab 11:10View ArticleGoogle Scholar

Copyright

© The Author(s) 2018

Advertisement